Literature DB >> 22665153

Relation between prefracture characteristics and perioperative complications in the elderly adult patient with hip fracture.

Christopher A Brown1, John Boling, Maria Manson, Thomas Owens, Robert Zura.   

Abstract

BACKGROUND: The exact relation among patient prefracture characteristics such as age, American Society of Anesthesiologists (ASA) class, fracture type, and prefracture mobility status with perioperative complications in elderly adult patients with hip fracture is still unclear. The aim of the study was to assess the relations among patient prefracture characteristics and perioperative complications.
METHODS: Patients 65 years old and older admitted to our institution between January 2006 and May 2010 with the diagnosis of a low-energy hip fracture were retrospectively reviewed. A total of 389 patients met the inclusion criteria and were analyzed in this investigation. Patient prefracture characteristics, comorbidities, and surgical and hospital courses were reviewed.
RESULTS: Using logistic regression analysis, ASA class was found to be the only significant predictor of a patient having at least one or more perioperative complications (odds ratio [OR] 2.007). In addition to ASA class, prefracture mobility status was a significant predictor of delirium (OR 1.39) and pneumonia (OR 1.77), advanced age was a significant predictor of congestive heart failure (OR 1.73), and fracture type was a significant predictor of pneumonia (OR 1.6). None of the examined prefracture characteristics was found to be a significant predictor of pulmonary embolus, deep venous thrombosis, surgical wounds, transfusions, urinary tract infection, or death.
CONCLUSIONS: At our institution, certain patient prefracture characteristics, particularly high ASA class, are related to certain perioperative complications. Recognition of patients who possess these risk factors can be used to alert the caregiving team about a potentially complicated hospital course.

Entities:  

Mesh:

Year:  2012        PMID: 22665153     DOI: 10.1097/SMJ.0b013e3182574bfd

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  6 in total

1.  Perioperative administration of methylprednisolone was associated with postoperative pulmonary complications in elderly patients undergoing hip fracture surgery.

Authors:  Jun Zhou; Chaojin Chen; Nan Cheng; Jibin Xing; Rongchang Guo; Lusi Li; Dong Yang; Ziqing Hei; Shaoli Zhou
Journal:  Aging Clin Exp Res       Date:  2022-08-04       Impact factor: 4.481

Review 2.  Postoperative management of hip fractures: interventions associated with improved outcomes.

Authors:  Cathleen S Colón-Emeric
Journal:  Bonekey Rep       Date:  2012-12-12

3.  Sex Differences in Hip Fracture Surgery: Preoperative Risk Factors for Delirium and Postoperative Outcomes.

Authors:  Esther S Oh; Frederick E Sieber; Jeannie-Marie Leoutsakos; Sharon K Inouye; Hochang B Lee
Journal:  J Am Geriatr Soc       Date:  2016-07-07       Impact factor: 5.562

4.  Complications after hip fracture surgery: are they preventable?

Authors:  E R Flikweert; K W Wendt; R L Diercks; G J Izaks; D Landsheer; M Stevens; I H F Reininga
Journal:  Eur J Trauma Emerg Surg       Date:  2017-08-09       Impact factor: 3.693

5.  Strict adherence to evidence-based protocol in choice of implants and surgical technique leads to fewer hip fracture reoperations.

Authors:  Elvira R Flikweert; Ronald L Diercks; Gerbrand J Izaks; Klaus W Wendt; Martin Stevens; Inge H F Reininga
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

6.  Activities of Daily Living and Determinant Factors among Older Adult Subjects with Lower Body Fracture after Discharge from Hospital: A Prospective Study.

Authors:  Nurul Izzah Ibrahim; Mohd Sharkawi Ahmad; Mohamed S Zulfarina; Sharifah Nurul Aqilah Sayed Mohd Zaris; Isa Naina Mohamed; Norazlina Mohamed; Sabarul Afian Mokhtar; Ahmad Nazrun Shuid
Journal:  Int J Environ Res Public Health       Date:  2018-05-16       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.